(Total Views: 158)
Posted On: 03/30/2022 8:46:00 AM
Post# of 103522
$AVCO Avalon GloboCare Adds CAR-NK Cell Therapies To Expand Cellular Immuno-Oncology Platform
Avalon GloboCare Corp (NASDAQ: AVCO) is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-NK) cell therapies.
https://finance.yahoo.com/news/avalon-globoca...21173.html
Avalon GloboCare Corp (NASDAQ: AVCO) is expanding its cellular immuno-oncology program with the addition of novel Chimeric Antigen Receptor – Natural Killer (CAR-NK) cell therapies.
https://finance.yahoo.com/news/avalon-globoca...21173.html
(0)
(0)Scroll down for more posts ▼
